Related Experiment Video
Updated: Jul 19, 2026

A Periprosthetic Joint Candida albicans Infection Model in Mouse
Published on: February 2, 2024
Orthopaedic implant infections
1Barnet and Chase Farm Hospitals NHS Trust, Barnet General Hospital, Wellhouse Lane, Barnet, Herts EN5 3DJ, UK.
Abstract:
Recent advances have defined risk factors for orthopaedic implant infections that suggest modifications in the clinical care of certain patients. For diagnosis, new work shows the importance of obtaining multiple specimens for culture, and the enlarging spectrum of causative organisms. The potential for the polymerase chain reaction is demonstrated. In treatment, the value of rifampicin is shown in controlled and open trials.
Insights
New findings identify risk factors for orthopaedic implant infections, emphasizing multiple cultures for diagnosis and the effectiveness of rifampicin in treatment. These advances suggest improved patient care strategies for preventing and managing these infections.
Area of Science:
- Orthopaedic surgery
- Infectious diseases
- Microbiology
Background:
- Orthopaedic implant infections pose significant challenges in patient care.
- Understanding risk factors is crucial for prevention and management.
- Current diagnostic and treatment protocols require continuous evaluation.
Purpose of the Study:
- To review recent advances in the diagnosis and treatment of orthopaedic implant infections.
- To highlight emerging risk factors and their clinical implications.
- To evaluate novel diagnostic techniques and therapeutic agents.
Main Methods:
- Review of recent literature on orthopaedic implant infections.
- Analysis of new diagnostic approaches, including polymerase chain reaction (PCR).
- Assessment of treatment strategies, focusing on the role of rifampicin.
Main Results:
- Identification of specific risk factors necessitating clinical care modifications.
- Demonstration of the importance of multiple cultures for accurate diagnosis.
- Expanded understanding of the spectrum of causative organisms.
- Evidence supporting the efficacy of rifampicin in controlled and open trials.
Conclusions:
- Advances in understanding risk factors can guide clinical practice modifications.
- Enhanced diagnostic methods, such as PCR and multiple cultures, improve pathogen detection.
- Rifampicin shows significant value in the treatment of orthopaedic implant infections.
- These developments offer improved strategies for managing orthopaedic implant infections.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Endocarditis IV: Nursing Management
Bacterial Signaling

